sistent with section 552 of title 5, United States Code, 
the Administrator shall publish, in electronic format, a 
publicly searchable database that contains information re-
garding the testing program. Not later than 30 days after 
the date on which the information becomes available, the 
Administrator shall ensure that, at a minimum, the data-
base— 
‘‘(1) identifies the substances selected for test-
ing under the program; and 
‘‘(2) includes the documents and information 
pertaining to the status of testing activities for each 
such substance, including test orders, deadlines for 
submission, the Environmental Protection Agency’s 
data evaluation records, the Administrator’s deter-
mination on whether regulatory action will be taken 
under subsection (f), and the summary of chemical 
test results. 
‘‘(h) PETITION FOR INCLUSION OF A SUBSTANCE IN 
THE PROGRAM.— 
‘‘(1) IN GENERAL.—Any person may submit a 
petition the Administrator to— 
‘‘(A) add a substance to the list under sub-
section (b)(1)(A) or identify a substance pursu-
ant to the plan under subsection (b)(1)(B); or 
VerDate Mar 15 2010 
02:34 May 19, 2010
Jkt 089200
PO 00000
Frm 00034
Fmt 6652
Sfmt 6201
E:\BILLS\H5320.IH
H5320
PWALKER on DSK8KYBLC1PROD with BILLS
‘‘(B) issue a test order requiring that a 
substance be tested on an accelerated basis in 
accordance with subsection (e). 
‘‘(2) SPECIFICATION OF FACTS.—Any petition 
under paragraph (1) shall specify the facts that are 
claimed to establish that an action described in sub-
paragraph (A) or (B) of paragraph (1) is warranted. 
‘‘(3) ADMINISTRATIVE ACTION.—Not later than 
90 days after the filing of a petition described under 
paragraph (1), the Administrator shall determine 
whether the petition has established that an action 
described in subparagraph (A) or (B) of paragraph 
(1) is warranted and shall grant or deny the peti-
tion. If the Administrator grants such petition, the 
Administrator shall promptly add the substance to 
the list under subsection (b)(1)(A), identify the sub-
stance pursuant to the plan under subsection 
(b)(1)(B), or issue an order requiring testing on an 
accelerated basis in accordance with subsection (e), 
as applicable. If the Administrator denies the peti-
tion, the Administrator shall publish the reasons for 
such denial in the Federal Register. 
‘‘(i) COORDINATION WITH OTHER FEDERAL AGEN-
CIES.—After the Administrator— 
‘‘(1) requires testing of a substance, or 
VerDate Mar 15 2010 
02:34 May 19, 2010
Jkt 089200
PO 00000
Frm 00035
Fmt 6652
Sfmt 6201
E:\BILLS\H5320.IH
H5320
PWALKER on DSK8KYBLC1PROD with BILLS
‘‘(2) based in whole or in part on the results of 
testing, takes action related to a substance under 
section 1412(b) or 1445 or other appropriate statu-
tory authority, 
the Administrator shall give notice of such testing or ac-
tion to Federal agencies which are authorized by other 
provisions of law to regulate the substance or products, 
materials, medications, processes, or practices that use the 
substance. 
‘‘(j) REPORTING REQUIREMENT.—Not later than 1 
year after the date of the enactment of the Endocrine 
Disruptor Screening Enhancement Act of 2010 and every 
3 years thereafter, the Administrator shall provide a re-
port to the Committee on Energy and Commerce of the 
House of Representatives and the Committee on Environ-
ment and Public Works of the Senate that describes— 
‘‘(1) progress made in identifying, testing, and 
regulating endocrine disruptors as well as plans for 
future activities; 
‘‘(2) any change in screening or testing method-
ology and evaluation or criteria for evaluating sci-
entifically relevant information; 
‘‘(3) actions taken to ensure communication 
and sharing of scientific information with other Fed-
eral agencies and the public; and 
VerDate Mar 15 2010 
02:34 May 19, 2010
Jkt 089200
PO 00000
Frm 00036
Fmt 6652
Sfmt 6201
E:\BILLS\H5320.IH
H5320
PWALKER on DSK8KYBLC1PROD with BILLS
‘‘(4) any deviations from the plan or schedule 
published under subsection (b)(1)(B) as well as the 
reasons therefor. 
‘‘(k) TESTING CONSORTIA, COMPENSATION, AND 
COMPLIANCE.— 
‘‘(1) IN GENERAL.—Any person required by the 
Administrator to conduct testing of an endocrine 
disruptor may— 
‘‘(A) submit, on its own, data in response 
to an order for such testing; and 
‘‘(B) form (on a voluntary basis) a consor-
tium in order to satisfy the requirements of one 
or more orders for such testing. 
‘‘(2) RELIANCE
ON
CONSORTIUM
SUBMIS-
SIONS.—Each member of a consortium described in 
paragraph (1)(B) shall have full rights to rely on all 
submissions of the consortium to satisfy the require-
ments of any order for testing, but continues to be 
individually subject to such requirements. 
‘‘(3) SHARING OF COSTS.— 
‘‘(A) IN
GENERAL.—Each member of a 
consortium described in paragraph (1)(B) shall 
share the applicable costs according to appro-
priate arrangements established by the consor-
tium members. 
VerDate Mar 15 2010 
02:34 May 19, 2010
Jkt 089200
PO 00000
Frm 00037
Fmt 6652
Sfmt 6201
E:\BILLS\H5320.IH
H5320
PWALKER on DSK8KYBLC1PROD with BILLS
‘‘(B) BINDING OFFER.—Whenever, to sat-
isfy the requirements of one or more orders for 
testing, any person offers to form or join a con-
sortium described in paragraph (1)(B), or of-
fers compensation to a person that has already 
submitted data to the Administrator satisfying 
an order for testing, such offer shall constitute 
a binding offer to share an appropriate portion 
of the applicable costs. 
‘‘(C) APPLICABLE
COSTS.—In this sub-
section, the term ‘applicable costs’ includes the 
costs— 
‘‘(i) incurred to generate and report 
information to comply with an order for 
testing; or 
‘‘(ii) associated with the organization 
and administration of the consortium. 
‘‘(4) DISPUTE RESOLUTION.— 
‘‘(A) IN GENERAL.—In the event of any 
dispute about an appropriate share or a fair 
method of determining an appropriate share of 
applicable costs of the testing requirements in 
a test order, any person involved in the dispute 
may initiate binding arbitration proceedings by 
requesting the Federal Mediation and Concilia-
VerDate Mar 15 2010 
02:34 May 19, 2010
Jkt 089200
PO 00000
Frm 00038
Fmt 6652
Sfmt 6201
E:\BILLS\H5320.IH
H5320
PWALKER on DSK8KYBLC1PROD with BILLS